Enovix price target lowered to $25 from $30 at Cantor Fitzgerald

Cantor Fitzgerald lowered the firm’s price target on Enovix (ENVX) to $25 from $30 and keeps an Overweight rating on the shares. Enovix missed the mark in Q3, reporting a cycle life issue with battery samples that led to a roughly one-quarter qualification push-out with its first smartphone customer, Honor, the analyst tells investors in a research note. Enovix is confident that commercial smartphone production will begin in Q2, Cantor notes, adding that the company is progressing nicely with smartphone OEMs and toward mass commercialization.

Meet Your ETF AI Analyst

Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

See the top stocks recommended by analysts >>

Read More on ENVX:

Disclaimer & DisclosureReport an Issue

Enovix price target lowered to $21 from $22 at Canaccord Enovix’s Strategic Partnership with Honor: A Buy Rating Amidst Challenges and Opportunities Enovix Corporation Reports Strong Q3 2025 Results Enovix sees Q4 non-GAAP EPS (16c)-(20c), consensus (14c) Enovix reports Q3 EPS (14c), consensus (16c)

View comments